Latest & greatest articles for pravastatin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pravastatin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pravastatin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pravastatin

3. Abdominal aortic aneurysm (AAA) screening clinical practice guideline.

Abdominal aortic aneurysm (AAA) screening clinical practice guideline. Abdominal aortic aneurysm (AAA) screening clinical practice guideline. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:007251 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's guidelines summaries contain information systematically

2010 Kaiser Permanente Care Management Institute

4. Screening for abdominal aortic aneurysm (AAA) reduced AAA mortality in Danish men 64–73 years of age

Screening for abdominal aortic aneurysm (AAA) reduced AAA mortality in Danish men 64–73 years of age Screening for abdominal aortic aneurysm (AAA) reduced AAA mortality in Danish men 64–73 years of age | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword (...) Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Screening for abdominal aortic aneurysm (AAA) reduced AAA mortality in Danish men 64–73 years of age Article Text Therapeutics Screening for abdominal aortic aneurysm (AAA) reduced AAA mortality in Danish men 64–73 years of age Free Jonathan A Michaels , MA, MChir, FRCS Statistics from Altmetric.com

2006 Evidence-Based Medicine (Requires free registration)

5. Elective endovascular treatment of the abdominal aortic aneurysm (AAA)

Elective endovascular treatment of the abdominal aortic aneurysm (AAA) Elective endovascular treatment of the abdominal aortic aneurysm (AAA) Elective endovascular treatment of the abdominal aortic aneurysm (AAA) Bonneux L, Cleemput I, Vrijens F, Vanoverloop J, Galloo P, Ramaekers D Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bonneux (...) L, Cleemput I, Vrijens F, Vanoverloop J, Galloo P, Ramaekers D. Elective endovascular treatment of the abdominal aortic aneurysm (AAA) Brussels: Belgian Health Care Knowledge Centre (KCE). KCE Reports 23B. 2005 Authors' objectives The objective of this study is to answer three specific questions: - What is the state of the art of effectiveness and cost-effectiveness of endovascular graft repair (EVAR) of abdominal aorta aneurysm (AAA), compared to watchful waiting and open repair? - For which

2005 Health Technology Assessment (HTA) Database.

6. Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men

Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men Article Text Economics Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men Free Jonathan

2004 Evidence-Based Medicine (Requires free registration)

7. Endovascular AAA treatment: expensive prestige or economic alternative

Endovascular AAA treatment: expensive prestige or economic alternative Endovascular AAA treatment: expensive prestige or economic alternative Endovascular AAA treatment: expensive prestige or economic alternative Holzenbein J, Kretschmer G, Glanzl R, Schon A, Thurnher S, Winkelbauer F, Trubel W, Minar E, Ahmadi A, Huk I, Ingruber H, Ehringer H, Lammer J, Polterauer P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Endovascular treatment of abdominal aortic aneurysm. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients due to undergo elective surgery for infrarenal AAA, aged between 54 and 84. Patients were excluded for the following reasons: complex aneurysms

1997 NHS Economic Evaluation Database.